A dermatite atopica (DA) e uma doenca cutanea pruriginosa, inflamatoria, cronica associada a anticorpos IgE alergeno-especificos principalmente voltados contra alergenos ambientais. A DA afeta diversas especies, incluindo caes e humanos e o prurido e o seu principal sinal clinico. Alemdisso, caes atopicos tendem a apresentar quadros recorrentes de piodermites bacterianas, associadas a alteracoes no microbioma tegumentar. Em alguns casos, os pacientes apresentam sinais clinicos tipicos de DA, mas anticorpos IgE alergeno-especificos nao podem ser detectados. Este subtipo de DA e chamado de dermatite atopica-like (ALD). Tanto as alteracoes no microbioma em caes atopicos quanto as caracteristicas da ALD ainda sao pouco estudadas em caes. Sendo assim, objetivou-se avaliar estes dois parametros distintos da DA. Para tal, o presente estudo foi dividido em duas partes. Na primeira parte, realizou-se um estudo retrospectivo dos prontuarios de 269 caes atendidos no hospital veterinario universitario da University of Minnesota, entre 2007 e 2015. Os pacientes foram divididos em dois grupos (AD e ALD) de acordo com os resultados dos testes alergicos. Foram avaliados e comparados entre os grupos dados epidemiologicos, gravidade da doenca de acordo com o grau de prurido, numero de areas corporeas afetadas, protocolo de tratamento de manutencao e resposta a terapia. A partir do grau medio de prurido e do numero medio de areas corporeas afetadas ao longo das visitas, foi criadoum indice de gravidade da dermatite atopica (CADSI) para se avaliar a intensidade da doenca em cada paciente e comparar entre os grupos ALD e AD. No grupo AD foram incluidos 228 caes (84,76%) e 41 no grupo ALD (15,24%). Nao foram observadas diferencas significativas entre os grupos nas variaveis epidemiologicas. Em relacao a predisposicao racial, o Bichon Frise apresentou mais risco de desenvolver ALD. Nao houve diferenca significativa no grau medio de prurido e numero de areas corporeas afetadas na primeira visita ou durante o tratamento entre os grupos, bem como na evolucao dessas variaveis ao longo das visitas. Quando o CADSI foicomparado entre os grupos, nao houve diferenca. Na segunda parte, foram selecionados prospectivamente sete caes atopicos com manifestacoes clinicas sazonais, alocados no Grupo Atopico (GA) e dez caes saudaveis, alocados no Grupo Controle (GC) e amostras foram coletadas da regiao interdigital, axilar, abdominal e lombar utilizando um suabe esteril. No GC, realizou-se seis coletas intervaladas de quatro semanas. No GA, as amostras foram coletadas quatro semanas antes do mes tipico de crise (Pre-crise), na crise antes de iniciar o tratamento (Crise), durante acrise com tratamento (Tratamento) e apos a estacao de crise, ja sem tratamento (Pos-crise). Apos as coletas, as amostras foram armazenadas refrigeradas por no maximo sete dias ate a extracao do DNA e sequenciamento do gene 16S rRNA. Apos o processamento, foi feita a analise bioinformatica e estatistica para avaliacao taxonomica e calculo de alpha e beta-diversidade. Os filos mais abundantes em todas as amostras foram Actinobacteria, Firmicutes, Fusobacteria e Proteobacteria. Observou-se que a diversidade do microbioma cutaneo de caes atopicos sofre reducao no Pre-crise e o tratamento imunomodulador e capaz de restabelece-la. Estes resultados sao muito relevantes e promissores pois demonstram as alteracoes na diversidade do microbioma antes mesmo do surgimento dos sinais clinicos da doenca e o papel restaurador da terapiaimunomoduladora, sem o uso de antimicrobianos. Atopic dermatitis (AD) is a chronic inflammatory, pruritic skin disease associated with allergenspecific IgE antibodies primarily against environmental allergens. AD affects several species, including dogs and humans. Pruritus is the main clinical sign of AD. In addition, atopic dogs tendto present recurrent superficial pyoderma, associated with alterations in the skin microbiome. In some cases, patients show typical clinical signs of AD, but allergen-specific IgE antibodies cannot be detected. This subtype of AD is called atopic-like dermatitis (ALD). Both the alterations in the skin microbiome of atopic dogs and the features of ALD are still poorly understood in dogs. Thus, we aimed to evaluate these two distinct parameters of AD. So, the present study was divided in two parts. In the first part, a retrospective study of the medical records of 269 dogs seen at the veterinary teaching hospital of the University of Minnesota between 2007 and 2015 was performed. Patients were divided in two groups (AD and ALD) according to the allergy testsresults. Epidemiological data, disease severity according pruritus level, number of affected body sites, maintenance treatment protocol and response to therapy were evaluated and compared between the groups. The mean pruritus level and the mean number of body sites affected across visits, the Canine Atopic Dermatitis Severity Index (CADSI) was created to assess the severity of the disease in each patient and to compare ALD and AD. In the AD group, 228 dogs (84.76%) were included and in the ALD group, 41 (15.24%). There were no significant differences between the groups in the epidemiological variables. In relation to breed predisposition, Bichon Frisé was more predisposed to developing ALD. There was no significant difference in the mean pruritus level and number of affected areas at the first visit or during treatment between groups, as well as in the outcome of these variables throughout the visits. When CADSI was compared betweengroups, there was no significant difference. In the second part, were selected prospectively seven seasonal atopic dogs, Atopic Group (GA), and ten healthy dogs, Control Group (CG). Samples were collected from the interdigital, axillary, abdominal and lumbar regions from each dog usinga sterile swab. In GC, six collections in a of four week interval were performed. In GA, the samples were collected four weeks prior the typical flare month (Pre-crisis), in the flare before starting the treatment (Flare), during the flare with treatment (Treatment) and after the flare seasonwithout treatment (Post-flare). After collection, samples were stored refrigerated for up to seven days until DNA extraction and sequencing of the 16S rRNA gene. After processing, bioinformatic and statistical analysis were performed for taxonomic evaluation and alpha and beta-diversityassessment. The most abundant phyla in all samples were Actinobacteria, Firmicutes, Fusobacteria and Proteobacteria. It was observed that the diversity of the cutaneous microbiome of atopic dogs undergoes a reduction the Pre-flare and the immunomodulatory treatment is able to reestablish it. These results are very relevant and promising as they demonstrate changes in microbiome diversity even before the inflammatory response of the disease and the restorative role of immunomodulatory therapy without the use of antimicrobials.